Scott M. Pittman - Net Worth and Insider Trading

Scott M. Pittman Net Worth

The estimated net worth of Scott M. Pittman is at least $2 Million dollars as of 2024-05-13. Scott M. Pittman is the Director, 10% Owner of Nuo Therapeutics Inc and owns about 2,935,800 shares of Nuo Therapeutics Inc (AURX) stock worth over $2 Million. Details can be seen in Scott M. Pittman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott M. Pittman has not made any transactions after 2017-08-10 and currently still holds the listed stock(s).

Transaction Summary of Scott M. Pittman

To

Scott M. Pittman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott M. Pittman owns 1 companies in total, including Nuo Therapeutics Inc (AURX) .

Click here to see the complete history of Scott M. Pittman’s form 4 insider trades.

Insider Ownership Summary of Scott M. Pittman

Ticker Comapny Transaction Date Type of Owner
AURX Nuo Therapeutics Inc 2018-12-31 director

Scott M. Pittman Latest Holdings Summary

Scott M. Pittman currently owns a total of 1 stock. Scott M. Pittman owns 2,935,800 shares of Nuo Therapeutics Inc (AURX) as of August 10, 2017, with a value of $2 Million.

Latest Holdings of Scott M. Pittman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AURX Nuo Therapeutics Inc 2017-08-10 2,935,800 0.80 2,348,640

Holding Weightings of Scott M. Pittman


Scott M. Pittman Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott M. Pittman has made a total of 0 transactions in Nuo Therapeutics Inc (AURX) over the past 5 years. The most-recent trade in Nuo Therapeutics Inc is the acquisition of 2,045,000 shares on August 10, 2017, which cost Scott M. Pittman around $613,500.

Insider Trading History of Scott M. Pittman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott M. Pittman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott M. Pittman Ownership Network

Ownership Network List of Scott M. Pittman

No Data

Ownership Network Relation of Scott M. Pittman


Scott M. Pittman Owned Company Details

What does Nuo Therapeutics Inc do?

Who are the key executives at Nuo Therapeutics Inc?

Scott M. Pittman is the director of Nuo Therapeutics Inc. Other key executives at Nuo Therapeutics Inc include 10 percent owner Charles E Sheedy , director & CEO & CFO David Emerson Jorden , and CSO Peter Clausen .

Nuo Therapeutics Inc (AURX) Insider Trades Summary

Over the past 18 months, Scott M. Pittman made no insider transaction in Nuo Therapeutics Inc (AURX). Other recent insider transactions involving Nuo Therapeutics Inc (AURX) include a net purchase of 212,500 shares made by Charles E Sheedy ,

In summary, during the past 3 months, insiders sold 0 shares of Nuo Therapeutics Inc (AURX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuo Therapeutics Inc (AURX) were sold and 212,500 shares were bought by its insiders, resulting in a net purchase of 212,500 shares.

Nuo Therapeutics Inc (AURX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nuo Therapeutics Inc Insider Transactions

No Available Data

Scott M. Pittman Mailing Address

Above is the net worth, insider trading, and ownership report for Scott M. Pittman. You might contact Scott M. Pittman via mailing address: 3683 John Nash Blvd., Bluefield Wv 24701.

Discussions on Scott M. Pittman

No discussions yet.